Search company, investor...

Greenovation Biotech

Founded Year



Other Investors | Alive

About Greenovation Biotech

greenovation Biotech GmbH is engaged in the production of pharmaceutically highly-efficient glycoproteins

Headquarters Location

Boetzinger Str. 29 b



Missing: Greenovation Biotech's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Greenovation Biotech's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Greenovation Biotech Patents

Greenovation Biotech has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Complement system
  • EC 3.4.21
patents chart

Application Date

Grant Date


Related Topics




Autosomal recessive disorders, Rare diseases, Clusters of differentiation, Molecular biology, EC 3.2.1


Application Date


Grant Date



Related Topics

Autosomal recessive disorders, Rare diseases, Clusters of differentiation, Molecular biology, EC 3.2.1



Latest Greenovation Biotech News

New data Provides Validation for Greenovations MossBased Expression System as a GMPCompliant Biopharmaceutical Production System Successful Collaboration with BioGenes

Mar 14, 2016

Advertisement Topics   Track topics on Twitter Track topics that are important to you Printed From New data Provides Validation for Greenovation’s Moss-Based Expression System as a GMP-Compliant Biopharmaceutical Production System - Successful Collaboration with BioGenes 06:59 EDT 14 Mar 2016 | Lab Bulletin Home » Topics » Biotechnology - Biotech » Latest News » New data Provides Validation for Greenovation’s Moss-Based Expression System as a GMP-Compliant Biopharmaceutical Production System - Successful Collaboration with BioGenes Scientists at BioGenes GmbH, Berlin and Greenovation Biotech GmbH, Freiburg, have cooperated to develop a novel host- cell protein (HCP) assay for Greenovation’s Physcomitrella patens expression system. The data have been published in the Journal BioProcess International in February 2016 by Dabrowska-Schlepp and colleagues. HCPs are inevitable impurities found in biopharmaceutical products originating from recombinant cell culture. HCPs are a heterogeneous mix of different proteins, and their specific characteristics depend on the kind of organism used as an expression platform. Contamination of a final drug substance with... Related Biotechnology, Pharmaceutical and Healthcare News

Greenovation Biotech Frequently Asked Questions (FAQ)

  • When was Greenovation Biotech founded?

    Greenovation Biotech was founded in 1999.

  • What is Greenovation Biotech's latest funding round?

    Greenovation Biotech's latest funding round is Other Investors.

  • Who are the investors of Greenovation Biotech?

    Investors of Greenovation Biotech include L-EigenkapitalAgentur, Gradus Venturenvestment Management, Mediport Venture, SeedFund and Zukunftsfonds Heilbronn.

  • Who are Greenovation Biotech's competitors?

    Competitors of Greenovation Biotech include Biolog, Hawaii Biotech, SenesTech, ugichem, Laureate Pharma and 13 more.

Compare Greenovation Biotech to Competitors

Biopolo S.c.r.l

Biopolo is devoted to support the biotech industry in Italy through technology transfer, management and communication.

ERA Biotech

ERA Biotech develops and implements cell-based biomanufacturing technologies.


Crison is engaged in the development and marketing of products for the biotech industry including buffers and amino acid derivatives.

bcs Biotech S.p.A.

bcs Biotech SpA is a biotech company based in Cagliari, Italy. The activities of BCS Biotech have focused on the design and production of PCR kits for the medical, veterinary and food processing markets. The years of start-up and research have led to the development of products and efficient quality-oriented manufacturing facilities. Recently, BCS has introduced a diagnostic system on microchips.nMEDICA 2008n

MI Research

MI Research, Inc. specializes in Biotech instrumentation with excellent visualization capabilities in the area of protein crystal growth and blood viscosity measurements. MI aims to offer fluorescence base protein crystallization prescreening service and biotech instruments like blood viscometers. MI's expertise is in optics and biochemistry.

BioPro Pharmaceutical

BioPro Pharmaceutical is the first regional biotech company in Asia to develop, market leading biopharmaceutical medicines, as well as many of the world's best known biopharmaceutical products. BioPro Pharmaceutical , Inc. has infrastructure in place in all major countries in Asia to target the market of US$30 billion. BioPro's expertise is in providing creative pharmaceutical solutions to small and medium-sized US or European companies by integrating Asia's respective business strengths in addressing the pharmaceutical needs of the Asia-Pacific region. We have the knowledge and know-how of the clinical and regulatory requirements across the Asian region . We manage more than 600 professional sales representatives. We are focused on the marketing and distribution of innovative biotech cancer products in Asian markets with the most cost-effective approaches. We anticipate intense competition in this new market sector, and are working diligently to stay at the forefront of this everchanging competitive environment. BioPro obtained the exclusive rights for the core patented technology - High Throughput Mammalian Protein Expression technology to develop cost effective protein products for bioassay and reagent support and " rapid mammalian production cell development technology and downstream support team for new generations of currently well-known and future protein drugs; We have three protein therapeutics, two antibody therapeutics and two vaccines under development.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.